Join to View Full Profile
20 Duke Medicine CircleDurham, NC 27710
Phone+1 919-668-6608
Dr. Uronis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Hope Uronis is an oncologist in Durham, NC and is affiliated with multiple hospitals in the area, including Duke University Hospital and Duke Regional Hospital. She received her medical degree from University at Buffalo School of Medicine and has been in practice 17 years. She specializes in gastrointestinal cancer and hematologic oncology and is experienced in hematologic oncology and gastrointestinal oncology. She has more than 60 publications and over 500 citings.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2003 - 2007- Duke University HospitalResidency, Internal Medicine, 2000 - 2003
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2000
Certifications & Licensure
NC State Medical License 2000 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma Start of enrollment: 2007 Feb 01
- A Phase I/Expansion Study of Dasatinib Start of enrollment: 2007 Apr 01
- QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer Start of enrollment: 2012 Jan 01
Publications & Presentations
PubMed
- Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED): A single-arm phase 2 trial.Pooja Karukonda, Brian G Czito, Eileen Duffy, Hope E Uronis, Thomas A D'Amico
Cancer. 2025-12-15 - ASO Author Reflections: Towards Personalized Cancer Therapy: The Role of ctDNA as a Biomarker in Patients with Unresectable Colorectal Liver Metastases Treated with He...Annie Liu, John Strickler, Hope Uronis, Michael E Lidsky
Annals of Surgical Oncology. 2025-10-01 - Circulating Tumor DNA as a Novel Prognostic Biomarker of Therapeutic Efficacy in Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial I...Annie Liu, Ellery H Reason, Brittany G Sullivan, Benjamin Wildman-Tobriner, John H Strickler
Annals of Surgical Oncology. 2025-10-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
